标题
Clinical overview of metronomic chemotherapy in breast cancer
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 12, Issue 11, Pages 631-644
出版商
Springer Nature
发表日期
2015-08-04
DOI
10.1038/nrclinonc.2015.131
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 178PGENERATION OF A PLASMA MICRORNA (MIRNA) SIGNATURE PREDICTING RESPONSE TO METRONOMIC CHEMOTHERAPY (MC) FOR ADVANCED BREAST CANCER (ABC)
- (2017) U. Emmenegger et al. ANNALS OF ONCOLOGY
- Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
- (2015) Lieke H J Simkens et al. LANCET
- On and off Metronomic Oral Vinorelbine in Elderly Women with Advanced Breast Cancer
- (2015) Francesca De Iuliis et al. TUMORI
- On and off Metronomic Oral Vinorelbine in Elderly Women with Advanced Breast Cancer
- (2015) Francesca De Iuliis et al. TUMORI JOURNAL
- Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
- (2015) Hideki Iwamoto et al. NEOPLASIA
- A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer
- (2014) N. Masuda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metronomics chemotherapy: time for computational decision support
- (2014) Dominique Barbolosi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metronomic therapy and breast cancer: A systematic review
- (2014) Emilia Montagna et al. CANCER TREATMENT REVIEWS
- Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
- (2014) J. M. Ebos et al. EMBO Molecular Medicine
- Bevacizumab in Combination with Metronomic Chemotherapy in Patients with Anthracycline- and Taxane-Refractory Breast Cancer
- (2014) J.A. García-Sáenz et al. JOURNAL OF CHEMOTHERAPY
- Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate
- (2014) A. Licchetta et al. JOURNAL OF CHEMOTHERAPY
- Metronomics: towards personalized chemotherapy?
- (2014) Nicolas André et al. Nature Reviews Clinical Oncology
- Factors responsible for long-term survival in metastatic breast cancer
- (2014) Keiichi Kontani et al. World Journal of Surgical Oncology
- Combining low-dose or metronomic chemotherapy with anticancer vaccines
- (2014) Heng Sheng Sow et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch
- (2014) Prabhat Singh Malik et al. Frontiers in Oncology
- The use of nanoparticulate delivery systems in metronomic chemotherapy
- (2013) De-Hong Yu et al. BIOMATERIALS
- Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
- (2013) Evangelos Briasoulis et al. BMC CANCER
- Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial
- (2013) Diana Crivellari et al. BREAST
- International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)–MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer
- (2013) Nancy U. Lin et al. BREAST
- Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
- (2013) H Inoue et al. CELL DEATH AND DIFFERENTIATION
- Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- (2013) Lee S. Schwartzberg et al. Clinical Breast Cancer
- Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
- (2013) Herman A Perroud et al. Future Oncology
- Precision Medicine for Cancer Patients: Lessons Learned and the Path Forward
- (2013) A. F. Gazdar et al. JNCI-Journal of the National Cancer Institute
- Has the time come for metronomics in low-income and middle-income countries?
- (2013) Nicolas André et al. LANCET ONCOLOGY
- The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
- (2013) Sean M. Geary et al. PLoS One
- Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
- (2013) Matilde Todaro et al. OncoImmunology
- Developments in the treatment of early NSCLC: when to use chemotherapy
- (2012) B. Besse et al. ANNALS OF ONCOLOGY
- Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) F. Cardoso et al. ANNALS OF ONCOLOGY
- Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab
- (2012) Silvia Dellapasqua et al. BREAST
- Oral Metronomic Cyclophosphamide and Methotrexate Plus Fulvestrant in Advanced Breast Cancer Patients: A Mono-Institutional Case-Cohort Report
- (2012) Gaetano Aurilio et al. Breast Journal
- Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
- (2012) Raffaele Addeo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
- (2012) D. T. Le et al. CANCER RESEARCH
- Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
- (2012) Emilia Montagna et al. Clinical Breast Cancer
- Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer
- (2012) S.D. Young et al. Current Oncology
- The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
- (2012) Fatima Cardoso et al. EUROPEAN JOURNAL OF CANCER
- Ischaemia-induced mucus barrier loss and bacterial penetration are rapidly counteracted by increased goblet cell secretory activity in human and rat colon
- (2012) Joep Grootjans et al. GUT
- Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
- (2012) Mariana S. Nars et al. INTERNATIONAL JOURNAL OF CANCER
- Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cellsin vitroin a TLR4-independent manner
- (2012) Tillmann Michels et al. Journal of Immunotoxicology
- Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
- (2012) Laura Biganzoli et al. LANCET ONCOLOGY
- Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer
- (2011) Silvia Dellapasqua et al. BREAST
- Phase I trial of metronomic oral vinorelbine in patients with advanced cancer
- (2011) Lakshmi Rajdev et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
- (2011) Zacharenia Saridaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study
- (2011) Zhonghua Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
- (2011) Yingzi Ge et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dose-Adjusting Capecitabine Minimizes Adverse Effects While Maintaining Efficacy: A Retrospective Review of Capecitabine for Metastatic Breast Cancer
- (2011) Robert Leonard et al. Clinical Breast Cancer
- Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1 in Advanced Solid Tumors
- (2011) S. Kummar et al. CLINICAL CANCER RESEARCH
- Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer
- (2011) P. Fedele et al. EUROPEAN JOURNAL OF CANCER
- Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity
- (2011) Sophie R. Sierro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer
- (2011) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
- (2011) Vincenzo Cerullo et al. MOLECULAR THERAPY
- Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
- (2011) Ramon Kaneno et al. CELLULAR ONCOLOGY
- Selective Depletion of CD4+CD25+Foxp3+Regulatory T Cells by Low-Dose Cyclophosphamide Is Explained by Reduced Intracellular ATP Levels
- (2010) Jie Zhao et al. CANCER RESEARCH
- Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
- (2010) Raffaele Addeo et al. Clinical Breast Cancer
- Up-to-date estimates of breast cancer survival for the years 2000–2004 in 11 European countries: The role of screening and a comparison with data from the United States
- (2010) Stefano Rosso et al. EUROPEAN JOURNAL OF CANCER
- Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas
- (2010) Leandro E. Mainetti et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Vinblastine in Children and Adolescents With High-Risk Anaplastic Large-Cell Lymphoma: Results of the Randomized ALCL99-Vinblastine Trial
- (2010) Marie-Cécile Le Deley et al. JOURNAL OF CLINICAL ONCOLOGY
- Nontoxic, Fiscally Responsible, Future of Oncology
- (2010) Giannoula Lakka Klement et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: A mono-institutional case-series report
- (2009) E. Munzone et al. BREAST
- Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial)
- (2009) Yasuo Ohashi et al. BREAST CANCER RESEARCH AND TREATMENT
- Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study
- (2009) Y Park et al. BRITISH JOURNAL OF CANCER
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
- (2009) Vedran Radojcic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
- (2009) J. M. L. Ebos et al. CLINICAL CANCER RESEARCH
- Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
- (2009) E. Briasoulis et al. CLINICAL CANCER RESEARCH
- Vascular targeting by EndoTAG™-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer
- (2009) Martin E. Eichhorn et al. INTERNATIONAL JOURNAL OF CANCER
- Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial
- (2009) Toru Watanabe et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response
- (2009) Nan Soon Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
- (2009) Ramon Kaneno et al. Journal of Translational Medicine
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exemestane: an alternative treatment option in early breast cancer
- (2008) Jacek Jassem ANTI-CANCER DRUGS
- Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity
- (2008) R Torrisi et al. BRITISH JOURNAL OF CANCER
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
- Maintenance treatment in metastatic breast cancer
- (2008) A Sánchez-Muñoz et al. Expert Review of Anticancer Therapy
- Preoperative Therapy in Invasive Breast Cancer: Pathologic Assessment and Systemic Therapy Issues in Operable Disease
- (2008) Julie R. Gralow et al. JOURNAL OF CLINICAL ONCOLOGY
- Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
- (2008) Silvia Dellapasqua et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now